Clinical evaluation on combined administration of oral prostacyclin analogue beraprost and phosphodiesterase inhibitor cilostazol

This publication has 9 references indexed in Scilit:

• Phase i study of beraprost sodium (TRK-100), a prostacyclin derivative-Single oral administration study.
  Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1989
• The in vitro and ex vivo antiplatelet effect of TRK-100, a stable prostacyclin analog, in several species.
  The Japanese Journal of Pharmacology, 1988
• Antithrombotic effect of TRK-100, a novel, stable PGI2 analogue.
  The Japanese Journal of Pharmacology, 1987
• Vasodilator actions of TRK‐100, a new prostaglandin I₂ analogue
  British Journal of Pharmacology, 1986
• Incorporation of synthetic 1,2‐diacylglycerol into platelet phosphatidylinositol is increased by cyclic AMP
  FEBS Letters, 1986
• Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor sepharose chromatography
  Biochemical Pharmacology, 1984
• Prostacyclin inhibition of phosphatidic acid synthesis in human platelets is not mediated by protein kinase C
  Biochemical and Biophysical Research Communications, 1984
• Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3′,5′-cyclic monophosphate and protein kinase
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1977
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
  Nature, 1962